{"version":"1.0","provider_name":"Gestion de capital PenderFund lt\u00e9e","provider_url":"https:\/\/penderfund.com\/fr","author_name":"Paige Collins","author_url":"https:\/\/penderfund.com\/fr\/author\/pcollins\/","title":"Pender Corporate Bond Fund - July 2025","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"5zPFBRXGVA\"><a href=\"https:\/\/penderfund.com\/fr\/commentaries\/pender-corporate-bond-fund-july-2025\/\">Fonds d'obligations de soci\u00e9t\u00e9s Pender - juillet 2025<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/penderfund.com\/fr\/commentaries\/pender-corporate-bond-fund-july-2025\/embed\/#?secret=5zPFBRXGVA\" width=\"600\" height=\"338\" title=\"&laquo; Pender Corporate Bond Fund - July 2025 &raquo; &#8212; PenderFund Capital Management\" data-secret=\"5zPFBRXGVA\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/penderfund.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","thumbnail_url":"https:\/\/penderfund.com\/wp-content\/uploads\/2025\/09\/PCBF.png","thumbnail_width":850,"thumbnail_height":400,"description":"The Pender Corporate Bond Fund enjoyed a profitable July, returning 1.5%[1]. The good result was due to a number of holding-specific catalyst events that allowed the Fund to outperform benchmarks. One key contributor for the period was our stake in the capital structure of Esperion Therapeutics Inc. Management\u2019s successful efforts in extending the cholesterol-lowering drug [&hellip;]"}